Current approaches to analgesic drug delivery for chronic pain

Technology and Health Care

Volumn 10, Issue 3-4, 2002, Pages 227-235

  Carr, Daniel B ^a   Sendil, Dilek ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Drug delivery; Pain; Polymer

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; BUTYROPHENONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CLONIDINE; CODEINE; DEXTROMETHORPHAN; DEXTROPROPOXYPHENE; FENTANYL; HALOPERIDOL; HYDROMORPHONE; IBUPROFEN; KETAMINE; LIDOCAINE; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETHIDINE; TIZANIDINE; TOPICAL AGENT;

ARTICLE; BACKACHE; CANCER PAIN; CHRONIC PAIN; DISEASE CONTROL; DRUG DELIVERY SYSTEM; DRUG EFFECT; HEADACHE; HEALTH CARE COST; HUMAN; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT;

EID: 0036036484     PISSN: 09287329     EISSN: None     Source Type: Journal    
DOI: 10.3233/thc-2002-103-408     Document Type: Article

References (40)

1. Classification of chronic pain: Descriptions of chronic pain syndrome and definition of pain terms
2. Management of chronic pain
3. Multimodal approach to control postoperative pathophysiology and rehabilitation
4. Trophic factors and pain
5. Spinal route of analgesia. Opioids and future options
6. Preempting the memory of pain
7. Acute pain
8. Chronic pain as an outcome of surgery. A review of predictive factors
9. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
10. Transition from acute to chronic pain
11. Pain
12. Assessing individual outcomes during outpatient, multidisciplinary chronic pain treatment by means of an augmented SF-36
13. Mechanisms of opioid analgetic actions
14. Neuropeptides: Peptide and nonpeptide analogs
15. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
16. Molecular characterization of opioid receptors
17. Clinical tolerance to opioids
18. Molecular and celular mechanisms in opioid tolerance
19. Analgesic tolerance to opioids
20. Interaction of spinal modulatory receptor systems
21. Controlled release pain management systems
22. Osmotic implantable delivery systems
23. Evidence-based review of the literature on intrathecal delivery of pain medications
24. Pain control via intrathecal polymeric implants
25. Pain reliever delivery from two different controlled release systems
26. Cancer pain relieved by long-term epidural morphine with permanent indwelling systems for self-administration
27. Spinal analgesia - Opioids, non-opioids and emerging options
28. Long-term spinal analgesic delivery: A review of the preclinical and clinical literature
29. Intrathecal drug therapy for chronic pain: From basic science to clinical practice
30. The spinal clonidine-opioid analgesic interaction: From laboratory animals to the postoperative ward. A literature review of preclinical and clinical evidence
31. Clinical guidelines for intraspinal infusion: Report of an expert panel
32. Improving the quality of reports on randomized controlled trials. Recommendations of the CONSORT study group
33. Future directions in the management of pain by intraspinal drug delivery
34. "Size is everything" - Large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects
35. A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic
36. The Cochrane Collaboration and its pain, palliative and supportive care review group